retatrutide safety trial is a new weight-loss injection, which is currently in its final stages of and efficacy trials. UK approval is likely in 2027, pending full MHRA review. Developed by Eli Lilly Retatrutide for Weight Loss: TRIUMPH-1
Pay in 4 interest-free payments of $5.06 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6


00967-0/asset/1cda1e69-507e-47d1-ad73-620bcd1cbb66/main.assets/gr2_lrg.jpg)




















